|
81
|
276
|
3tucA |
Crystal structure of syk kinase domain with 1-benzyl-n-(5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-yl)-2-oxo-1,2-dihydropyridine-3-carboxamide |
|
85
|
277
|
3svvA |
Crystal structure of t338c c-src covalently bound to vinylsulfonamide-pyrazolopyrimidine 9 |
|
91
|
291
|
6aamA |
Crystal structure of tyk2 in complex with peficitinib |
|
91
|
290
|
6aahA |
Crystal structure of jak1 in complex with peficitinib |
|
84
|
284
|
6aakA |
Crystal structure of jak3 in complex with peficitinib |
|
91
|
288
|
6aajA |
Crystal structure of jak2 in complex with peficitinib |
|
80
|
265
|
5xy1A |
Crystal structure of lyn kinase domain in complex with n-(1h-indazol-6-yl)-8-(piperidin-4-yloxy)-6-propylquinazolin-2-amine |
|
67
|
263
|
5xyzA |
The structure of human btk kinase domain in complex with a covalent inhibitor |
|
91
|
332
|
5uadA |
Met tyrosine kinase inhibition enhances the antitumor efficacy of an hgf antibody |
|
89
|
289
|
5ng3B |
Structure of inactive kinase rip2k(k47r) |
|
89
|
290
|
5ng3A |
Structure of inactive kinase rip2k(k47r) |
|
84
|
294
|
5ng2A |
Structure of rip2k(d146n) with bound staurosporine |
|
84
|
293
|
5njzA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with compound 1g |
|
67
|
284
|
5tc0A |
Structure-based optimization of 1h-imidazole-2-carboxamides as axl kinase inhibitors utilizing a mer mutant surrogate |
|
75
|
276
|
5swhA |
C-src v281c kinase domain in complex with rao-iv-151 |
|
85
|
284
|
5mjaA |
Kinase domain of human ephb1 bound to a quinazoline-based inhibitor |
|
85
|
284
|
5mjbA |
Kinase domain of human ephb1, g703c mutant, covalently bound to a quinazoline-based inhibitor |
|
134
|
449
|
5mo4A |
Abl1 kinase (t334i_d382n) in complex with asciminib and nilotinib |
|
95
|
290
|
5lwnA |
Crystal structure of jak3 in complex with compound 5 (fm409) |
|
89
|
271
|
5lmbA |
Human spleen tyrosine kinase kinase domain in complex with azanaphthyridine inhibitor |
|
96
|
290
|
5lwmA |
Crystal structure of jak3 in complex with compound 4 (fm381) |
|
83
|
274
|
5l6pA |
Ephb3 kinase domain covalently bound to an irreversible inhibitor (compound 6) |
|
86
|
274
|
5l6oA |
Ephb3 kinase domain covalently bound to an irreversible inhibitor (compound 3) |
|
98
|
297
|
5kx8A |
Irak4-inhibitor co-structure |
|
78
|
276
|
5knjA |
Pseudokinase domain of mlkl bound to compound 1. |
|
94
|
314
|
5kmmA |
Trka jm-kinase with 1-(2-methyl-4-phenyl-pyrimidin-5-yl)-3-(1-naphthyl)urea |
|
95
|
323
|
5kmlA |
Trka jm-kinase with 1-(5-methyl-3-phenyl-1,2-oxazol-4-yl)-3-[[2-(trifluoromethyl)phenyl]methyl]urea |
|
90
|
315
|
5kmkA |
Trka jm-kinase with 2-fluoro-{n}-[2-(4-fluorophenyl)-6-methyl-3-pyridyl]-4-(trifluoromethyl)benzamide |
|
94
|
290
|
5l3aA |
Fragment-based discovery of 6-arylindazole jak inhibitors |
|
85
|
279
|
5ko1A |
Pseudokinase domain of mlkl bound to compound 4. |
|
93
|
323
|
5kmnA |
Trka jm-kinase with 1-(2-methyl-4-phenyl-pyrimidin-5-yl)-3-[[2-(trifluoromethyl)phenyl]methyl]urea |
|
91
|
265
|
5kupA |
Bruton's tyrosine kinase (btk) with pyridazinone compound 9 |
|
86
|
298
|
5kmoA |
Trka jm-kinase with 1-(2-methyl-4-phenyl-pyrimidin-5-yl)-3-(2-pyridyl)urea |
|
76
|
268
|
5kx7A |
Irak4-inhibitor co-structure |
|
52
|
283
|
5kkrB |
Ksr2:mek1 complex bound to the small molecule aps-2-79 |
|
94
|
310
|
5kmjA |
Trka jm-kinase with {n}-(2-pyridylmethyl)-2-[2-(2-thienyl)indol-1-yl]acetamide |
|
85
|
291
|
5kvtA |
The structure of trka kinase domain bound to the inhibitor entrectinib |
|
95
|
311
|
5kmiA |
Trka jm-kinase with 1-(9{h}-fluoren-9-yl)-3-(2-methyl-4-phenyl-pyrimidin-5-yl)urea |
|
90
|
294
|
5k76A |
Irak4 in complex with compound 28 |
|
74
|
288
|
5k0xA |
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase mer in complex with inhibitor unc2541 |
|
75
|
298
|
5jkgA |
The crystal structure of fgfr4 kinase domain in complex with ly2874455 |
|
84
|
305
|
5jfvA |
Crystal structure of trka in complex with pf-05206283 |
|
88
|
323
|
5j9yA |
Egfr-t790m in complex with pyrazolopyrimidine inhibitor 1b |
|
89
|
288
|
5khxA |
Crystal structure of jak1 in complex with pf-4950736 |
|
85
|
295
|
5k7iA |
Irak4 in complex with az3864 |
|
82
|
277
|
5jsmA |
Brafv600e kinase domain in complex with chemically linked vemurafenib inhibitor vem-3-vem |
|
86
|
305
|
5jfwA |
Crystal structure of trka in complex with pf-05247452 |
|
87
|
307
|
5jgbA |
Crystal structure of human tak1/tab1 fusion protein in complex with ligand 10 |
|
93
|
295
|
5k7gA |
Irak4 in complex with az3862 |
|
83
|
273
|
5jrqA |
Brafv600e kinase domain in complex with chemically linked vemurafenib inhibitor vem-6-vem |
